Ziegler R, Eisenbarth G S
Joslin Diabetes Center, New England Deaconess Hospital, Boston, Mass.
Horm Res. 1990;33(2-4):144-50; discussion 150-1. doi: 10.1159/000181498.
The prodromal phase of type I diabetes is characterized by the presence of a series of autoantibodies reacting with distinct autoantigens [anti-insulin, anti-64 kDa, islet cell antibodies ('antiganglioside')]. Anti-insulin autoantibodies appear to be unique in that the levels of such antibodies correlate with both the rate of progression to diabetes and age at which type I diabetes develops. With a combination of assays it is now possible to predict type I diabetes, allowing the design of research trials for diabetes prevention.